Biokinetics data of lung-administered PEI F25-LMW/siRNA polyplexes within different lung compartments are presented. Thereby, at three different timepoints (1 h, 3 h, 8 h), the data was determined by calculations to the 32 P-radioactivity in the whole mouse body. Additionally, data was optimized to the available PEI F25-LMW/siRNA polyplexes in the target organ and therefore normalized to the sum of all lung compartments. Methods, other biokinetics data and the discussion of the results are published in "Biokinetic studies of non-complexed siRNA versus nano-sized PEI F25-LMW/siRNA polyplexes following intratracheal instillation into mice" (Lipka et al., 2016 [1] P-siRNA nanoscale complexes (polyplexes) and non-complexed 32 P-siRNA within the lungs.
Specifications Table

Subject area
Pharmacy More specific subject area
Biopharmacy of nano-sized polyplexes
Type of data Figure  How data Data serve as one potential risk assessment factor for polyplexes of the same / similar size that are supposed to be applied to the lungs.
Data serve as a comparison value to other nano-sized spheres either in regard to the applied dose (total animal) or in regard to the available dose in the target organ (lungs).
Data
The diagram of Fig. 1 shows the biokinetics (measured 32 P-radioactivity) of non-complexed 32 P-siRNA and PEI F25-LMW complexed 32 P-siRNA within different lung compartments after intratracheal instillation. Data points were relatively calculated to the radioactivity in the whole mouse body. While only limited data is available in the literature, the second figure focuses on the uptake by broncho alveolar (BAL) cells in regard to the available PEI F25-LMW/siRNA polyplexes in the lung (Fig. 2) .Thereby allowing for a direct comparison to results of a former study by Semmler-Behnke et al. [3] 2. Experimental design, materials and methods PEI F25-LMW/ 32 P-siRNA polyplexes and non-complexed 32 P-siRNA were prepared as fully described in [1] . Either non-complexed siRNA or PEI F25-LMW/ 32 P-siRNA polyplexes were intratracheally instilled to groups of animals. At each time point (1 h, 3 h and 7 h), a minimum of three animals were exsanguinated, all organs, blood and carcass were collected. A bronchoalveolar lavage (BAL) was performed. BAL suspension was centrifuged in order to distinguish between BAL cells and BAL fluid. Samples were treated with nitric acid (50% v/v; one ml per mg sample weight) to obtain homogenous solutions for an analysis via LSC (liquid scintillation counting; beta-radio analysis). Values were corrected for background radiation and blood content within each organ. Either the sum of all animal samples or the sum of all lung-related samples served as denominator for the percentage calculation. All steps are described in detail in [1] .
Acknowledgements
This work was in part supported by a grant from the German Research Foundation (FOR627 "Nanohale") to AA and WK.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi. org/10.1016/j.dib.2016.03.092. P-siRNA polyplexes in BAL/lung compartments after i.t. instillation into mice [2] . Values are given in mean7SEM (nZ3). *Significantly different to the 1 h value. § -Significantly different to the 3 h value.
